Sabra Health Care REIT, Inc.
Company Stats
- Market Cap
- $5.0B
- as of Sep 30, 2026
- Enterprise Value
- $7.5B
- Shares Outstanding
- 255.5M
- Free Float
- 98.6%
Income Statement
- Revenue
- $774.6M
- Net Income
- $155.6M
- Revenue Growth, 3Y
- 7.4%
- FCF Margin, 3Y Avg
- 36.4%
- FCF Margin, Worst Year
- 33.3%
Cash Flow
- Free Cash Flow
- $307.1M
- FCF Yield
- 6.1%
- Owner FCF Yield
- 5.9%
Balance Sheet
- Cash & Equivalents
- $71.5M
- Total Debt
- $2.6B
- Net Debt
- $2.5B
Returns & Capital
- Dividends Paid
- $289.5M
- Dividend Yield
- 5.7%
- Dividend Payout, 3Y Avg
- 808.0%
- SBC, 3Y Avg
- $9.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $774.6M | $307.1M | 39.6% |
| FY2024 | $703.2M | $255.8M | 36.4% |
| FY2023 | $647.5M | $215.7M | 33.3% |
| FY2022 | $624.8M | $261.3M | 41.8% |
| FY2021 | $569.5M | $313.7M | 55.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges